* Sotera Health Co SHC.OQ SHC.O is expected to show a
rise in
quarterly revenue when it reports results on February 27 for
the period ending December 31 2023
* The Broadview Heights Ohio-based company is expected to
report
a 20.1% increase in revenue to $302.148 million from $251.59
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data. (Sales is on Total Revenue basis)
* LSEG's mean analyst estimate for Sotera Health Co is for
earnings of 26 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Sotera
Health Co
is $16.50, below its last closing price of $16.60.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 0.20 0.20 0.21 Beat 6.2
Jun. 30 2023 0.17 0.18 0.21 Beat 19.9
Mar. 31 2023 0.14 0.14 0.13 Missed -4.5
Dec. 31 2022 0.22 0.22 0.25 Beat 14.1
Sep. 0.22 0.22 0.23 Beat 2.8
30 2022
Jun. 30 2022 0.24 0.24 0.27 Beat 11.3
Mar. 31 2022 0.19 0.19 0.22 Beat 13.6
Dec. 31 2021 0.22 0.22 0.23 Beat 3.8
This summary was machine generated February 23 at 16:24 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)